Science

Dermatological mail-in PCR laboratories

Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 13. article by Prof Hans-Jürgen Tietz, Director of the Institute of Fungal Diseases in Berlin, Germany   I often receive questions from dermatologists describing events in their mycological mail-in laboratory. In my opinion, the establishment of local laboratory collectives is an excellent development. […]

Science

Free public antibody testing in Böblingen: EUROIMMUN provides tests for pilot project in Southern Germany

Since 23 February 2022, residents of the district of Böblingen can receive one of 4000 free COVID-19 antibody tests offered by pharmacist Dr Björn Schittenhelm. By determining their antibody titers, the pharmacy’s pilot project aims to give double vaccinated residents the possibility to better determine when to get their booster jabs and to be more

Science

Of wrestling mats and hair salons

Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 12th article by Prof Hans-Jürgen Tietz, Director of the Institute of Fungal Diseases in Berlin, Germany Mycoses spring in every nook and cranny. It is not only a recent phenomenon that patients get a fungal infection with their haircut, but since the easing

Science

The beacons of dermatology

Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 11th article by Prof Hans-Jürgen Tietz, Director of the Institute of Fungal Diseases in Berlin, Germany Fungal cultures and their aesthetically pleasing structures will always hold a special place in my heart, but even I must admit that the introduction of PCR into

Science

New guideline recognises anti-PLA2R as a significant biomarker for membranous nephropathy

In October 2021, the organisation KDIGO (Kidney Disease: Improving Clinical Outcomes) published an updated version of the clinical guideline for the management of patients with glomerulonephritis. This guideline contains recommendations for diagnostics in primary membranous nephropathy, an autoimmune kidney disease that is characterised in most cases by the occurrence of autoantibodies against PLA2R and/or THSD7A. The

Scroll to Top